The content on this site is intended for healthcare professionals only
Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
WIN 2012
28 - 29 Jun 2012
France
The WINTHER study
Prof Razelle Kurzrock - MD Anderson Cancer Center, Houston, USA
16 Jul 2012
Use of electronic data to raise the standard of cancer care
Brett Davis – Oracle Corporation, USA
16 Jul 2012
Drugging the cancer genome: opportunities and challenges
Prof Paul Workman - Institute of Cancer Research, UK
16 Jul 2012
A new direction for development of targeted cancer therapies
Dr Edison Liu – Jackson Laboratory, USA
16 Jul 2012
Online collaborations to aid treatment development
Dr Patrick Johnson - Dassault Systems, France
13 Jul 2012
Addressing Asia’s high cancer incidence
Dr Bin Teh - SingHealth Group, Singapore
13 Jul 2012
Vandetanib increases progression free survival in medullary thyroid carcinoma
Dr Nick Botwood - AstraZeneca, UK
13 Jul 2012
WINTHER: The WIN therapeutics clinical trial
Prof Josep Tabernero - Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Sp...
13 Jul 2012
Use of genetic variance to identify potential therapeutic targets
Dr John Quackenbush - Dana-Farber Cancer Institute, Boston, USA
11 Jul 2012
Introduction of PET tracers to the WINTHER trial
Robert Dann - Global Strategy Leader, Oncology/Pathology, GE Healthcare
11 Jul 2012
Application of next generation sequencing
Dr Gary Palmer – Foundation Medicine, Cambridge, USA
6 Jul 2012
Next generation sequencing and WIN therapeutics
Dr Michael Pellini – Foundation Medicine, Cambridge, USA
6 Jul 2012
Identifying targets with systems medicine
Dr Leroy Hood – Institute for Systems Biology, USA
6 Jul 2012
Importance of early detection and the ‘Beyond the Shock’ programme
Dr Douglas Feil – National Breast Cancer Foundation, USA
6 Jul 2012
Shortening the timeline for clinical drug developments
Dr James Doroshow – National Cancer Institute, Bethesda, USA
6 Jul 2012
Building international collaborations and the WINTHER trial
Dr Oliver Bogler – MD Anderson Cancer Center, Houston, USA
6 Jul 2012
